Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Sunday share tips: Ceres Power, Invinity Energy Systems

(Sharecast News) - The Sunday Times's Lucy Tobin recommended investors buy Ceres Power in anticipation of imminent revenue growth.

Ceres had seen its share price crash since 2021, most recently due to delays due to regulatory delays in China which were delaying a 'milestone' manufacturing agreement with Weichai and Bosch.

But Tobin pointed out that the deal had only been delayed, not dumped.

Worth noting, the Asian giant was still expected to become Ceres's largest market.

Its technology was also notable with the company working with Shell on solid oxide electrolyser cells that could produce hydrogen 20% more efficiently.

And the company wasn´t scaling the manufacturing process itself, instead it licensed its technology to royalty paying partners.

So revenue growth was imminent as more deals were inked.

Indeed, two factories were set to start producing and selling hydrogen products beginning from the back half of 2024.

Analysts at Panmure Gordon concurred with analyst Lacie Midgley saying: "Ceres today is in a much stronger position than two years ago [when the share price was £15].

"It has that pending China [deal], royalties will be feeding through in under a year, two factories are gearing up - the business is miles ahead."

The Financial Mail on Sunday's Midas column tipped shares of Invinity Energy Systems to readers, predicting that the energy storage engineer's fortunes were set to change.

Invinity Energy Systems was formed via a tie-up of US-based Avalon and AIM-listed vanadium battery producer RedT.

In its previous incarnation, RedT had been a consistent disappointment.

Invinity had recently teamed up with Siemens however to develop Mistral, vanadium flow batteries with upfront costs similar to lithium batteries but lifetime costs that were significantly lower.

And commercial sales were expected from 2024.

Wind power was now the largest source of energy for the UK, but too little wind meant that turbines underperformed, whilst too much wind meant they were asked to stop producing.

That was making renewable energy more expensive that it need be and slowing the energy transition.

Lithium batteries could be used to store power to solve the problem of variable wind speeds, but they were best used for short bursts of power, degraded quickly and were highly flammable.

That was not the case for vanadium flow batteries.

Furthermore, Invinity had already sold more vanadium batteries than any other supplier.

And interest in the company's products was surging with projects under way in Australia, Canada and California.

"Backing a loss-making business is never without risk but Invinity is now working hand in glove with engineering powerhouse Siemens and has attracted support from around the world," Midas said.

"At 35p, the shares should go far."

Share this article

Related Sharecast Articles

Thursday newspaper round-up: Thames Water, mortgage costs, UK car production
(Sharecast News) - Thames Water has breached its licence to supply water to nearly 16 million people after some of its debt was downgraded to junk status. The regulator Ofwat could now fine Thames, the country's largest water monopoly, up to 10% of its annual turnover, equating to hundreds of millions of pounds. However, since the company is already teetering close to temporary renationalisation, Ofwat is likely to hold off on any immediate large fines. - Guardian
Wednesday newspaper round-up: Reckitt, Tesla, Virgin Atlantic...
(Sharecast News) - Reckitt is under pressure from top shareholders to revisit a sale of its nutrition business, following litigation and a series of other setbacks at the division that have sent the company's share price to decade lows. The FTSE 100 consumer giant acquired the Mead Johnson infant formula business in 2017 for $17bn - its largest-ever acquisition - and it has been plagued by mishaps ever since. Meanwhile, the wider group, which makes Lysol detergent and Durex condoms, has underwhelmed investors as it struggles to build back sales volumes following a period of high inflation and suppressed consumer demand. - Financial Times
Tuesday newspaper round-up: Kamala Harris, Crowdstrike, Vivendi...
(Sharecast News) - Kamala Harris has secured enough delegates from her party to clinch the Democratic presidential nomination, as she pledged to offer Americans a "brighter future" compared to the "chaos, fear and hate" proposed by Donald Trump. The US vice-president was speaking in Wilmington, Delaware, on Monday, the first full day since President Joe Biden dropped his re-election bid and endorsed her for the Democratic presidential nomination, shaking up the 2024 race for the White House. - Financial Times
Monday newspaper round-up: Biden, gambling levy, UK economy...
(Sharecast News) - Kamala Harris, the vice-president, has emerged as the frontrunner to replace President Biden as the Democratic nominee for the election against Donald Trump in November. Biden, 81, announced yesterday afternoon that he would drop out of the race. In the hours that followed, Harris, 59, was endorsed by leading Democrats, prospective rivals and the chairs of all 50 state parties. - The Times

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.